Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.

BACKGROUND : A recent study has shown that triple anti-platelet therapy (cilostazol+clopidogrel+aspirin) resulted in a significantly lower restenosis rate after coronary stenting than did conventional therapy (clopidogrel+aspirin). However, the anti-platelet effects of cilostazol, when combined with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Korean J Intern Med
Hlavní autoři: Ahn, Jeong Cheon, Song, Woo Hyuk, Kwon, Jung Ah, Park, Chang Gyu, Seo, Hong Seok, Oh, Dong Joo, Rho, Young Moo
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Association of Internal Medicine 2004
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531578/
https://ncbi.nlm.nih.gov/pubmed/15683111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2004.19.4.230
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky